Profile Core value Main business Legitimacy Social Responsibility
    Patents Research Direction Technology Strength
  API Intermediates Side chain for Paclitaxel and Docetaxel N-1 stage
  Production management QC Quality System branch factory




  Products Center
Paclitaxel (Semi-synthetic)
Paclitaxel (Natural)
Docetaxel Anhydrous
Docetaxel Trihydrate
Irinotecan HCl Trihydrate 99.5%
Etoposide USP31
Palonosetron Hydrochloride
  N-1 stage of Paclitaxel and Docetaxel
  Main Intermediates
10-Deacetylbaccatin III
Baccatin III
  Side chain for Paclixel semi-Synthetic
(4S,5R)-3-(N-benzoyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain of Docetaxel
(4S,5R)-3-(N-tert-butoxycarbony)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid
  Side chain for Paclitaxel and Docetaxel
Ethyl (2R,3S)-3-Phenylisoserine Ester
Your location:Home>>R & D>>Technology Strength

Our R&D center is located in Central Shanghai, currently equipped with 18 R&D professionals and a full set of experimental equipments.

In the high-tech industry, technology innovation is the primary driven force and source strength for the company's continuous development. The company centers on innovation, aims at the internationally advanced, domestical blank and continuable projects, deeply committed in research and development. By taking in full consideration of reasonable arrangement for short term and long term projects, it is able to complement the basic research and the applicable development, maintain its leading position in the R&D of Anti-cancer APIs and its relevant products.

CopyRight(C)2006,Shanghai Jinhe Bio-Pharmaceutical Co.,Ltd. All Rights Reserved. Supported by ChemNet ChinaChemNet Toocle Copyright Notice ChemNet
HOME About us Products R & D Production and QA Contact us CHINESE
疯狂之七电子游戏 彩神平刷软件靠谱吗 山西快乐10分 pk10倍投稳赚比例 不用投资就可以赚钱的 三肖六码码中特心水 皇朝2娱乐官网 股票配资是什么意思 电玩城龙虎技巧 今天黑龙江22选5开奖 极速快3稳赚公式 乐彩网排列三六码遗漏组六分析 入驻头条号怎么赚钱 湖北十一选开奖结果查询 重庆时时彩龙虎近100期 广西快三形势走势图 重庆时时开奖结果直播视频